These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13833029)

  • 1. [New data on the Hageman and P.T.A. factors and on the "contact"].
    SOULIER JP; PROU-WARTELLE O
    Rev Fr Etud Clin Biol; 1959 Nov; 4():932-8. PubMed ID: 13833029
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential characteristics of Hageman & P.T.A. factors; role of contact in the initial phase of coagulation].
    SOULIER JP; WARTELLE O; MENACHE D
    Rev Fr Etud Clin Biol; 1958 Mar; 3(3):263-7. PubMed ID: 13555201
    [No Abstract]   [Full Text] [Related]  

  • 3. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ONE-STAGE ASSAY FOR HAGEMAN FACTOR (FACTOR XII). FURTHER STUDIES ON THE ROLE OF HAGEMAN FACTOR IN BLOOD COAGULATION.
    HAANEN C; SCHOENMAKERS JG
    Thromb Diath Haemorrh; 1963 Jul; 18():557-69. PubMed ID: 14072245
    [No Abstract]   [Full Text] [Related]  

  • 5. The recognition of Hageman deficiency in blood donors.
    MARSH WL; JENKINS WJ
    J Clin Pathol; 1961 Sep; 14(5):550-1. PubMed ID: 14470228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the contact factor (Hageman factor) in fibrinolysis].
    NIEWIAROWSKI S; PROU-WARTELLE O
    Thromb Diath Haemorrh; 1959 Sep; 3():593-603. PubMed ID: 14427142
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of Hageman factor by collagen.
    Wilner GD; Nossel HL; LeRoy EC
    J Clin Invest; 1968 Dec; 47(12):2608-15. PubMed ID: 4302176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hageman factor and disseminated intravascular coagulation (DIC) in newborns and rabbits.
    Corrigan JJ; Sell EJ; Pagel C
    Pediatr Res; 1977 Aug; 11(8):916-20. PubMed ID: 887313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
    RATNOFF OD; DAVIE EW; MALLETT DL
    J Clin Invest; 1961 May; 40(5):803-19. PubMed ID: 13739760
    [No Abstract]   [Full Text] [Related]  

  • 11. Arginine esterase activity of the contact (Hageman) factor.
    NIEWIAROWSKI S; STACHURSKA J; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1962 Jul; 7():514-22. PubMed ID: 14479714
    [No Abstract]   [Full Text] [Related]  

  • 12. [LIVER AND BLOOD COAGULATION. I. BEHAVIOR OF FACTOR XII (HAGEMAN), OF FACTOR X (STUART) AND OF FIBRINOGEN IN LIVER PATIENTS].
    BOLANDRINA E; SOARDI F
    Gazz Int Med Chir; 1964 Jan; 68():63-79. PubMed ID: 14123792
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on contact activation: effects of surface and inhibitors.
    Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
    Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hageman factor activation.
    Nossel HL; Rubin H; Drillings M; Hsieh R
    J Clin Invest; 1968 May; 47(5):1172-80. PubMed ID: 5645860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of activated Hageman factor on the blood coagulation system in vivo].
    Ashkinazi IIa; Klemina IK
    Biull Eksp Biol Med; 1970 Apr; 69(4):32-6. PubMed ID: 5487897
    [No Abstract]   [Full Text] [Related]  

  • 18. Hageman trait: an asymptomatic disorder of blood coagulation.
    RATNOFF OD; MARGOLIUS A
    Trans Assoc Am Physicians; 1955; 68():149-54. PubMed ID: 13299324
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation studies in a case of Hageman trait.
    LOELIGER EA; HENSEN A
    Thromb Diath Haemorrh; 1960 Dec; 5():187-200. PubMed ID: 13763095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.